Stephen J Kanes Selected Research

Headache (Headaches)

1/2023	Zuranolone in Major Depressive Disorder: Results From MOUNTAIN-A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
1/2022	A phase 1 double-blind, placebo-controlled study of zuranolone (SAGE-217) in a phase advance model of insomnia in healthy adults.
1/2019	Trial of SAGE-217 in Patients with Major Depressive Disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen J Kanes Research Topics

Disease

10	Schizophrenia (Dementia Praecox) 04/2014 - 03/2004
9	Postpartum Depression (Post-Natal Depression) 01/2023 - 01/2017
7	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 01/2019
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023 - 01/2022
3	Headache (Headaches) 01/2023 - 01/2019
2	Nausea 01/2023 - 01/2019
2	Sleepiness 01/2023 - 01/2019
2	Dizziness (Lightheadedness) 01/2023 - 01/2019
2	Fatigue 01/2023 - 01/2022
1	Diarrhea 01/2023
1	Tremor (Tremors) 02/2021
1	Pancreatitis 01/2021
1	Confusion (Bewilderment) 01/2021
1	Status Epilepticus (Complex Partial Status Epilepticus) 09/2017
1	Coma (Comas) 09/2017
1	Memory Disorders (Memory Loss) 02/2008
1	AIDS-Related Complex (ARC) 02/2008
1	Ageusia (Hypogeusia) 02/2007
1	Neoplasms (Cancer) 04/2004
1	Hepatitis 04/2004

Drug/Important Bio-Agent (IBA)

10	zuranoloneIBA 01/2023 - 01/2019
7	Tuberculin (PPD)IBA 01/2023 - 01/2017
5	brexanoloneIBA 01/2023 - 01/2017
3	Pregnanolone (Allopregnanolone)IBA 10/2020 - 01/2017
3	Phenylthiourea (Phenylthiocarbamide)IBA 12/2012 - 04/2005
2	NeurosteroidsIBA 01/2023 - 10/2020
2	GTP-Binding Proteins (G-Protein)IBA 02/2008 - 03/2004
2	N-Methylaspartate (NMDA)IBA 01/2006 - 06/2004
2	Ketamine FDA LinkGeneric 01/2006 - 06/2004
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2023
1	nasIBA 02/2021
1	Dopamine (Intropin)FDA LinkGeneric 02/2021
1	Dopamine Agents (Dopaminergic Agents)IBA 02/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2019
1	Anesthetics (Anesthetic Agents)IBA 09/2017
1	Progesterone FDA LinkGeneric 01/2017
1	Neurokinin-3 ReceptorsIBA 04/2014
1	3- ((methylsulfonyl)amino)- 2- phenyl- N- (1- phenylpropyl)quinolin- 4- carboxamideIBA 04/2014
1	Genetic Markers (Genetic Marker)IBA 12/2012
1	Messenger RNA (mRNA)IBA 02/2008
1	Ethanol (Ethyl Alcohol)IBA 11/2006
1	GlucocorticoidsIBA 05/2006
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2004
1	Interferon-alpha (Interferon Alfa)IBA 04/2004
1	Olanzapine (Zyprexa)FDA Link 04/2004
1	Haloperidol (Haldol)FDA LinkGeneric 04/2004
1	Gs GTP-Binding Protein alpha Subunits (G(s)alpha)IBA 03/2004

Therapy/Procedure

2	Therapeutics 02/2021 - 09/2017